214 related articles for article (PubMed ID: 30804329)
1. CXCR7 promotes melanoma tumorigenesis via Src kinase signaling.
Xu S; Tang J; Wang C; Liu J; Fu Y; Luo Y
Cell Death Dis; 2019 Feb; 10(3):191. PubMed ID: 30804329
[TBL] [Abstract][Full Text] [Related]
2. The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo.
Zhang H; Yang L; Teng X; Liu Z; Liu C; Zhang L; Liu Z
Tumour Biol; 2016 Feb; 37(2):2415-23. PubMed ID: 26383519
[TBL] [Abstract][Full Text] [Related]
3. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth.
Jeong HJ; Oh HA; Nam SY; Han NR; Kim YS; Kim JH; Lee SJ; Kim MH; Moon PD; Kim HM; Oh HA
Int J Cancer; 2013 Jun; 132(11):2492-501. PubMed ID: 23161568
[TBL] [Abstract][Full Text] [Related]
4. Chemokine receptor 7 targets the vascular endothelial growth factor via the AKT/ERK pathway to regulate angiogenesis in colon cancer.
Li X; Wang X; Li Z; Zhang Z; Zhang Y
Cancer Med; 2019 Sep; 8(11):5327-5340. PubMed ID: 31348616
[TBL] [Abstract][Full Text] [Related]
5. CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
Yamada K; Maishi N; Akiyama K; Towfik Alam M; Ohga N; Kawamoto T; Shindoh M; Takahashi N; Kamiyama T; Hida Y; Taketomi A; Hida K
Int J Cancer; 2015 Dec; 137(12):2825-36. PubMed ID: 26100110
[TBL] [Abstract][Full Text] [Related]
6. CXCR7 as a chemokine receptor for SDF-1 promotes gastric cancer progression via MAPK pathways.
Shi A; Shi H; Dong L; Xu S; Jia M; Guo X; Wang T
Scand J Gastroenterol; 2017; 52(6-7):745-753. PubMed ID: 28281844
[TBL] [Abstract][Full Text] [Related]
7. β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation.
Kallifatidis G; Munoz D; Singh RK; Salazar N; Hoy JJ; Lokeshwar BL
Mol Cancer Res; 2016 May; 14(5):493-503. PubMed ID: 26921391
[TBL] [Abstract][Full Text] [Related]
8. CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression.
Lin L; Han MM; Wang F; Xu LL; Yu HX; Yang PY
Cell Death Dis; 2014 Oct; 5(10):e1488. PubMed ID: 25341042
[TBL] [Abstract][Full Text] [Related]
9. Role of chemokine receptor CXCR7 in bladder cancer progression.
Hao M; Zheng J; Hou K; Wang J; Chen X; Lu X; Bo J; Xu C; Shen K; Wang J
Biochem Pharmacol; 2012 Jul; 84(2):204-14. PubMed ID: 22525723
[TBL] [Abstract][Full Text] [Related]
10. Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signaling.
Wei ST; Huang YC; Hsieh ML; Lin YJ; Shyu WC; Chen HC; Hsieh CH
Cell Death Dis; 2020 May; 11(5):307. PubMed ID: 32366833
[TBL] [Abstract][Full Text] [Related]
11. Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo.
Maussang D; Mujić-Delić A; Descamps FJ; Stortelers C; Vanlandschoot P; Stigter-van Walsum M; Vischer HF; van Roy M; Vosjan M; Gonzalez-Pajuelo M; van Dongen GA; Merchiers P; van Rompaey P; Smit MJ
J Biol Chem; 2013 Oct; 288(41):29562-72. PubMed ID: 23979133
[TBL] [Abstract][Full Text] [Related]
12. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
[TBL] [Abstract][Full Text] [Related]
13. CXCR7/p-ERK-Signaling Is a Novel Target for Therapeutic Vasculogenesis in Patients with Coronary Artery Disease.
Cao Z; Tong X; Xia W; Chen L; Zhang X; Yu B; Yang Z; Tao J
PLoS One; 2016; 11(9):e0161255. PubMed ID: 27612090
[TBL] [Abstract][Full Text] [Related]
14. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.
Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X
J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244
[TBL] [Abstract][Full Text] [Related]
15. CXCR7 in tumorigenesis and progression.
Hou KL; Hao MG; Bo JJ; Wang JH
Chin J Cancer; 2010 Apr; 29(4):456-9. PubMed ID: 20346226
[TBL] [Abstract][Full Text] [Related]
16. RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.
Bai Y; Yang Y; Yan Y; Zhong J; Blee AM; Pan Y; Ma T; Karnes RJ; Jimenez R; Xu W; Huang H
Theranostics; 2019; 9(12):3459-3475. PubMed ID: 31281490
[No Abstract] [Full Text] [Related]
17. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
[TBL] [Abstract][Full Text] [Related]
18. Gastrin promotes angiogenesis by activating HIF-1α/β-catenin/VEGF signaling in gastric cancer.
Tang E; Wang Y; Liu T; Yan B
Gene; 2019 Jul; 704():42-48. PubMed ID: 30980943
[TBL] [Abstract][Full Text] [Related]
19. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
20. The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation.
Salazar N; Muñoz D; Kallifatidis G; Singh RK; Jordà M; Lokeshwar BL
Mol Cancer; 2014 Aug; 13():198. PubMed ID: 25168820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
